---
title: "LRMR: Nomlabofusp shows sustained FXN increases, clinical benefit, and advances toward accelerated approval"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291130146.md"
description: "FDA alignment supports a rolling BLA submission for nomlabofusp in Friedreich's ataxia, with positive open-label data showing sustained FXN increases and clinical improvements over 1–18 months. Safety profile remains consistent, and Phase 3 dosing is planned for Q3 2026.Original document: Larimar Therapeutics, Inc. [LRMR] Press release — Jun. 29 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-06-29T10:36:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291130146.md)
  - [en](https://longbridge.com/en/news/291130146.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291130146.md)
generator: "portal-rs"
---

# LRMR: Nomlabofusp shows sustained FXN increases, clinical benefit, and advances toward accelerated approval

FDA alignment supports a rolling BLA submission for nomlabofusp in Friedreich's ataxia, with positive open-label data showing sustained FXN increases and clinical improvements over 1–18 months. Safety profile remains consistent, and Phase 3 dosing is planned for Q3 2026.

Original document: Larimar Therapeutics, Inc. \[LRMR\] Press release — Jun. 29 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [LRMR.US](https://longbridge.com/en/quote/LRMR.US.md)

## Related News & Research

- [Putprop extends Dobsonville lease with Larimar at monthly rent of R 314,608](https://longbridge.com/en/news/297025361.md)
- [Hennion & Walsh Asset Management Inc. Purchases New Position in Larimar Therapeutics, Inc. $LRMR](https://longbridge.com/en/news/295771398.md)
- [AI Was Supposed to Kill Wix. Google Just Gave It a Way to Fight Back.](https://longbridge.com/en/news/297433684.md)
- [The Bot Now Clicks Buy: Your AI Is About To Start Spending Your Money](https://longbridge.com/en/news/297424265.md)
- [Taysha Gene Therapies highlights TSHA-102 Rett gene therapy path toward BLA submission in corporate presentation](https://longbridge.com/en/news/297550820.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**